An AI-based EGFR biomarker tool could preclude the need for a rapid PCR test in nearly half of advanced lung adenocarcinoma cases, a study has suggested.

A multidisciplinary guideline panel convened by the American Association of Bronchology and Interventional Pulmonology (AABIP ...

Recognizing that breast cancer guidelines, much like those for lung cancer, are constantly evolving, Tempus is working to ...

The available evidence suggests that guided-bronchoscopy sampling is of similar adequacy for comprehensive biomarker testing compared to percutaneous biopsy, while consistently demonstrating a better ...

With EAGLE, lung cancer biopsy analysis is expedited, accurately predicting EGFR mutations and streamlining the diagnostic process for better patient outcomes.

You may have seen print or television ads promoting the Galleri blood test for “early cancer detection.” Neither this test nor any others are covered by Medicare or commercial insurance, but you can ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Lung function tests (or pulmonary function tests) include a variety of tests that check how well the lungs work.

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, ...

Lord's - the Home of Cricket - once again turned red for the Ruth Strauss Foundation's annual #RedforRuth day, held on the ...

A LIFESAVING cancer screening pop-up shop will head to Barnsley town centre next week in order to continue testing more...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...